Drug recall · May 23, 2018
Piperacillin and Tazobactam for Injection recall
Why: Subpotent Drug: High Levels of Impurities Resulting in Decrease Potency
Class I: a reasonable chance the product could cause serious harm or death.
The recall
- Product
Piperacillin and Tazobactam for Injection, USP 4.5 gram/vial* 10-count Single Use Vials per carton, Rx only, Mfg. by: Hospira Healthcare India Pvt. Ltd. Irungattukottai-602 105, India Mfg. for: Apotex Corp. Weston, FL 33326. NDC 60505-0688-4
- Lots / codes
Lots: 502H001 Exp. 01/2019; 502H003, 502H004, 502H005, Exp. 04/2019; 502H009, 502H012, Exp. 05/2019.
- Quantity
- 13453 vials
- Company
- Apotex Inc., North York
- Distribution
- Nationwide in the USA.
- Initiated
- May 8, 2018 · Voluntary: Firm initiated
- Classified
- June 5, 2018
- Reported
- May 23, 2018
- Ended
- October 3, 2023
- How notified
- Letter
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.